Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 959 products on this category.

Product data	Purity	Price range	Estimated delivery
Palbociclib Impurity 45 REF: 4Z-P-196052CAS: 193902-78-2	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 75 REF: 4Z-C-121078	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 51 REF: 4Z-C-121054	- - -	To inquire	Tue 10 Dec 24
Olaparib Impurity 9 REF: 4Z-O-032011CAS: 414910-15-9	- - -	To inquire	Tue 10 Dec 24
Olaparib Impurity 57 REF: 4Z-O-032062	- - -	To inquire	Tue 10 Dec 24
Enzalutamide Impurity 56 HCl REF: 4Z-E-068070CAS: 177960-04-2	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 52 REF: 4Z-C-121055CAS: 2049024-27-1	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 64 REF: 4Z-C-121067	- - -	To inquire	Tue 10 Dec 24
4-Bromo-2-fluorobenzamide REF: 4Z-E-068018CAS: 292621-45-5	- - -	To inquire	Tue 10 Dec 24
Palbociclib Impurity 62 REF: 4Z-P-196069	- - -	To inquire	Tue 10 Dec 24
Bestatin Impurity 22 REF: 4Z-B-119025	- - -	To inquire	Tue 10 Dec 24
Fulvestrant Impurity 14 REF: 4Z-F-3122	- - -	To inquire	Tue 10 Dec 24
Abiraterone Impurity 9 REF: 4Z-A-8246	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 83 REF: 4Z-N-066096CAS: 14235-05-3	- - -	To inquire	Tue 10 Dec 24
Palbociclib Impurity 78 REF: 4Z-P-196085	- - -	To inquire	Tue 10 Dec 24
Palbociclib Impurity 41 REF: 4Z-P-196048	- - -	To inquire	Tue 10 Dec 24
Carfilzomib REF: TM-T1795CAS: 868540-17-4	99.6% - 99.84%	52.00 €~176.00 €	Tue 10 Dec 24
Nintedanib Impurity 51 REF: 4Z-N-066069CAS: 444667-11-2	- - -	To inquire	Tue 10 Dec 24
Leuprorelin (Leuprolide)-d5 REF: 4Z-PL-412	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 44 REF: 4Z-N-066062CAS: 262368-30-9	- - -	To inquire	Tue 10 Dec 24

5mg		52.00 €
10mg		73.00 €
25mg		94.00 €
50mg		134.00 €
100mg		176.00 €

Cancer treatment

Palbociclib Impurity 45

Ref: 4Z-P-196052

Carfilzomib Impurity 75

Ref: 4Z-C-121078

Carfilzomib Impurity 51

Ref: 4Z-C-121054

Olaparib Impurity 9

Ref: 4Z-O-032011

Olaparib Impurity 57

Ref: 4Z-O-032062

Enzalutamide Impurity 56 HCl

Ref: 4Z-E-068070

Carfilzomib Impurity 52

Ref: 4Z-C-121055

Carfilzomib Impurity 64

Ref: 4Z-C-121067

4-Bromo-2-fluorobenzamide

Ref: 4Z-E-068018

Palbociclib Impurity 62

Ref: 4Z-P-196069

Bestatin Impurity 22

Ref: 4Z-B-119025

Fulvestrant Impurity 14

Ref: 4Z-F-3122

Abiraterone Impurity 9

Ref: 4Z-A-8246

Nintedanib Impurity 83

Ref: 4Z-N-066096

Palbociclib Impurity 78

Ref: 4Z-P-196085

Palbociclib Impurity 41

Ref: 4Z-P-196048

Carfilzomib

Ref: TM-T1795

Nintedanib Impurity 51

Ref: 4Z-N-066069

Leuprorelin (Leuprolide)-d5

Ref: 4Z-PL-412

Nintedanib Impurity 44

Ref: 4Z-N-066062